Characterization of metallo-β-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3570-3572

  Papagiannitsis, C C ^a   Kotsakis, S D ^b   Petinaki, E ^c   Vatopoulos, A C ^a   Tzelepi, E ^b   Miriagou, V ^b   Tzouvelekis, L S ^b,d  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SERINE; TICARCILLIN; UNCLASSIFIED DRUG; VIM 1 METALLO BETA LACTAMASE; VIM 27 METALLO BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENZYME STRUCTURE; GENE SEQUENCE; INTEGRON; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN HYDROLYSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFOXITIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; IMIPENEM; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE;

EID: 79959278154     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00238-11     Document Type: Article

References (16)

1. Cornaglia, G., et al. 2007. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380-388.
2. Diancourt, L., V. Passet, J. Verhoef, P. A. Grimont, and S. Brisse. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182.
3. Docquier, J.-D., et al. 2003. On functional and structural heterogeneity of VIM-type metallo-β-lactamases. J. Antimicrob. Chemother. 51:257-266.
4. Gacar, G. G., et al. 2005. Genetic and enzymatic properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob. Agents Chemother. 49:4400-4403.
5. Garau, G., et al. 2004. Update of the standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 48:2347-2349.
6. Kotsakis, S. D., V. Miriagou, E. Tzelepi, and L. S. Tzouvelekis. 2010. Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases. Antimicrob. Agents Chemother. 54:4864-4871.
7. Lassaux, P., et al. 2011. Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4. Antimicrob. Agents Chemother. 55:1248-1255.
8. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
9. Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
10. Mavroidi, A., et al. 2001. An integron-associated β-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum β-lactamase IBC-1. J. Antimicrob. Chemother. 48:627-630.
11. Miriagou, V., E. Tzelepi, D. Gianneli, and L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1. Antimicrob. Agents Chemother. 47:395-397.
12. VIM-1 in a clinical strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:4026-4028.
13. Robin, F., N. Aggoune-Khinache, J. Delmas, M. Naim, and R. Bonnet. 2010. Novel VIM metallo-β-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob. Agents Chemother. 54:466-470.
14. Rodriguez-Martinez, J.-M., P. Nordmann, N. Fortineau, and L. Poirel. 2010. VIM-19, a metallo-β-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471-476.
15. Vatopoulos, A. 2008. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece - a review of the current evidence. Euro Surveill. 13:8023.
16. Vatopoulos, A. C., A. Philippon, L. S. Tzouvelekis, Z. Z. Komninou, and N. J. Legakis. 1990. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J. Antimicrob. Chemother. 26:635-648.